For example, we showed recently that HDACI treatment in an animal model of PD results in neuroprotection, associated with upregulation of brain derived neurotrophic factor (BDNF), glial derived neurotrophic factor (GDNF), and anti-apoptotic factor B-Cell Lymphoma 2 (BCL-2) [21]. This evidence concerns the gene BDNF and Parkinson disease.